Technetium Tc-99m Tilmanocept Patent Expiration
Technetium Tc-99M Tilmanocept was first introduced by Cardinal Health 414 Llc Cardinal Health Nuclear Pharmacy Services
Technetium Tc-99m Tilmanocept Patents
Given below is the list of patents protecting Technetium Tc-99m Tilmanocept, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lymphoseek Kit | US9439985 | Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran | Jan 30, 2029 | Cardinal Health 414 |
| Lymphoseek Kit | US6409990 | Macromolecular carrier for drug and diagnostic agent delivery | May 12, 2025 | Cardinal Health 414 |
Technetium Tc-99m Tilmanocept's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List